Laura joined Osborne Clarke in 2012 and specializes in international M&A transactions as well as in corporate governance matters with respect to listed companies.
During her years of experience advising in M&A transactions, she has worked with a variety of high-profile clients, including a listed company in Spain which is one of the world leaders in plasma-based products. She also advises this client on a broad range of matters related to corporate governance.
Laura was seconded to our London office in 2014, where she worked in the corporate team and assisted in M&A transactions.
Laura has been recognised by the Iberian Lawyer as a Top 50 rising star “dolphin” in 2021. Read more here
Osborne Clarke advises Grifols on strategic USD 1 billion investment from GIC. Read more >
Osborne Clarke advises Grifols in its strategic alliance with Shanghai RAAS. Read more >
OC assists Grifols with 25 plasma centres acquisition for $370m. Read more >
Osborne Clarke assists Grifols in its strategic alliance with the Egyptian government to boost plasma-derived medicines self-sufficiency in the Middle East and Africa. Read more >